APO Research
Talk to an analyst

APO RESEARCH · REPORT

NK Cells

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global NK Cells Market Outlook and Growth Opportunities 2026

22 December 2025196 pages

Choose your research edition.

Industry ResearchNK Cells Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal NK Cells Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal NK Cells Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NK Cells Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal NK Cells Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global NK Cells market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NK Cells is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the NK Cells market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the NK Cells market include Affimed NV, Altor BioScience, Chipscreen Biosciences, Fortress Biotech, Henry Ford Health Services, Innate Pharma, NantKwest, NKT and Sorrento Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global NK Cells market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NK Cells and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NK Cells sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the NK Cells market size, projected growth trends, production technologies, key applications, and end-use industries.

NK Cells Segment by Company

Affimed NV

Altor BioScience

Chipscreen Biosciences

Fortress Biotech

Henry Ford Health Services

Innate Pharma

NantKwest

NKT

Sorrento Therapeutics

Bristol-Myers Squibb

Takeda

NK Cells Segment by Type

Mogamulizumab

Lorvotuzumab Mertansine

Others

NK Cells Segment by Application

Cancer

Cardiovascular Diseases

Others

NK Cells Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global NK Cells status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions NK Cells market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify NK Cells significant trends, drivers, influence factors in global and regions.

6. To analyze NK Cells competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NK Cells market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NK Cells and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NK Cells.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the NK Cells market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NK Cells industry.

Chapter 3: Detailed analysis of NK Cells manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of NK Cells in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of NK Cells in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. NK Cells Industry Trends Table 2. NK Cells Industry Drivers Table 3. NK Cells Industry Opportunities and Challenges Table 4. NK Cells Industry Restraints Table 5. Global NK Cells Revenue by Company (US$ Million) & (2021-2026) Table 6. Global NK Cells Revenue Share by Company (2021-2026) Table 7. Global NK Cells Sales Volume by Company (g) & (2021-2026) Table 8. Global NK Cells Sales Volume Share by Company (2021-2026) Table 9. Global NK Cells Average Price (US$/g) of Company (2021-2026) Table 10. Global NK Cells Company Ranking, (2024-2026) & (USD Million) Table 11. Global NK Cells Key Company Manufacturing Base & Headquarters Table 12. Global NK Cells Company, Product Type & Application Table 13. Global NK Cells Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global NK Cells by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Mogamulizumab Table 18. Significant Companies of Lorvotuzumab Mertansine Table 19. Significant Companies of Others Table 20. Global NK Cells Sales Volume by Type 2021 VS 2025 VS 2032 (g) Table 21. Global NK Cells Sales Volume by Type (2021-2026) & (g) Table 22. Global NK Cells Sales Volume by Type (2027-2032) & (g) Table 23. Global NK Cells Sales Volume Share by Type (2021-2026) Table 24. Global NK Cells Sales Volume Share by Type (2027-2032) Table 25. Global NK Cells Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global NK Cells Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global NK Cells Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global NK Cells Sales Value Share by Type (2021-2026) Table 29. Global NK Cells Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Cancer Table 31. Significant Companies of Cardiovascular Diseases Table 32. Significant Companies of Others Table 33. Global NK Cells Sales Volume by Application 2021 VS 2025 VS 2032 (g) Table 34. Global NK Cells Sales Volume by Application (2021-2026) & (g) Table 35. Global NK Cells Sales Volume by Application (2027-2032) & (g) Table 36. Global NK Cells Sales Volume Share by Application (2021-2026) Table 37. Global NK Cells Sales Volume Share by Application (2027-2032) Table 38. Global NK Cells Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global NK Cells Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global NK Cells Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global NK Cells Sales Value Share by Application (2021-2026) Table 42. Global NK Cells Sales Value Share by Application (2027-2032) Table 43. Global NK Cells Sales by Region: 2021 VS 2025 VS 2032 (g) Table 44. Global NK Cells Sales by Region (2021-2026) & (g) Table 45. Global NK Cells Sales Market Share by Region (2021-2026) Table 46. Global NK Cells Sales by Region (2027-2032) & (g) Table 47. Global NK Cells Sales Market Share by Region (2027-2032) Table 48. Global NK Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global NK Cells Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global NK Cells Sales Value Share by Region (2021-2026) Table 51. Global NK Cells Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global NK Cells Sales Value Share by Region (2027-2032) Table 53. Global NK Cells Market Average Price (US$/g) by Region (2021-2026) Table 54. Global NK Cells Market Average Price (US$/g) by Region (2027-2032) Table 55. Global NK Cells Sales by Country: 2021 VS 2025 VS 2032 (g) Table 56. Global NK Cells Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global NK Cells Sales by Country (2021-2026) & (g) Table 58. Global NK Cells Sales Market Share by Country (2021-2026) Table 59. Global NK Cells Sales by Country (2027-2032) & (g) Table 60. Global NK Cells Sales Market Share by Country (2027-2032) Table 61. Global NK Cells Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global NK Cells Sales Value Market Share by Country (2021-2026) Table 63. Global NK Cells Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global NK Cells Sales Value Market Share by Country (2027-2032) Table 65. Affimed NV Company Information Table 66. Affimed NV Business Overview Table 67. Affimed NV NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 68. Affimed NV NK Cells Product Portfolio Table 69. Affimed NV Recent Development Table 70. Altor BioScience Company Information Table 71. Altor BioScience Business Overview Table 72. Altor BioScience NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 73. Altor BioScience NK Cells Product Portfolio Table 74. Altor BioScience Recent Development Table 75. Chipscreen Biosciences Company Information Table 76. Chipscreen Biosciences Business Overview Table 77. Chipscreen Biosciences NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 78. Chipscreen Biosciences NK Cells Product Portfolio Table 79. Chipscreen Biosciences Recent Development Table 80. Fortress Biotech Company Information Table 81. Fortress Biotech Business Overview Table 82. Fortress Biotech NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 83. Fortress Biotech NK Cells Product Portfolio Table 84. Fortress Biotech Recent Development Table 85. Henry Ford Health Services Company Information Table 86. Henry Ford Health Services Business Overview Table 87. Henry Ford Health Services NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 88. Henry Ford Health Services NK Cells Product Portfolio Table 89. Henry Ford Health Services Recent Development Table 90. Innate Pharma Company Information Table 91. Innate Pharma Business Overview Table 92. Innate Pharma NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 93. Innate Pharma NK Cells Product Portfolio Table 94. Innate Pharma Recent Development Table 95. NantKwest Company Information Table 96. NantKwest Business Overview Table 97. NantKwest NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 98. NantKwest NK Cells Product Portfolio Table 99. NantKwest Recent Development Table 100. NKT Company Information Table 101. NKT Business Overview Table 102. NKT NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 103. NKT NK Cells Product Portfolio Table 104. NKT Recent Development Table 105. Sorrento Therapeutics Company Information Table 106. Sorrento Therapeutics Business Overview Table 107. Sorrento Therapeutics NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 108. Sorrento Therapeutics NK Cells Product Portfolio Table 109. Sorrento Therapeutics Recent Development Table 110. Bristol-Myers Squibb Company Information Table 111. Bristol-Myers Squibb Business Overview Table 112. Bristol-Myers Squibb NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 113. Bristol-Myers Squibb NK Cells Product Portfolio Table 114. Bristol-Myers Squibb Recent Development Table 115. Takeda Company Information Table 116. Takeda Business Overview Table 117. Takeda NK Cells Sales (g), Value (US$ Million), Price (US$/g) and Gross Margin (2021-2026) Table 118. Takeda NK Cells Product Portfolio Table 119. Takeda Recent Development Table 120. Key Raw Materials Table 121. Raw Materials Key Suppliers Table 122. NK Cells Distributors List Table 123. NK Cells Customers List Table 124. Research Programs/Design for This Report Table 125. Authors List of This Report Table 126. Secondary Sources Table 127. Primary Sources List of Figures Figure 1. NK Cells Product Image Figure 2. Global NK Cells Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global NK Cells Sales Value (2021-2032) & (US$ Million) Figure 4. Global NK Cells Sales (2021-2032) & (g) Figure 5. Global NK Cells Sales Average Price (US$/g) & (2021-2032) Figure 6. Global NK Cells Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Mogamulizumab Image Figure 10. Lorvotuzumab Mertansine Image Figure 11. Others Image Figure 12. Global NK Cells Sales Volume by Type (2021 VS 2025 VS 2032) & (g) Figure 13. Global NK Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global NK Cells Sales Volume Share by Type (2021-2032) Figure 15. Global NK Cells Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global NK Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global NK Cells Sales Value Share by Type (2021-2032) Figure 18. Cancer Image Figure 19. Cardiovascular Diseases Image Figure 20. Others Image Figure 21. Global NK Cells Sales Volume by Application (2021 VS 2025 VS 2032) & (g) Figure 22. Global NK Cells Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global NK Cells Sales Volume Share by Application (2021-2032) Figure 24. Global NK Cells Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global NK Cells Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global NK Cells Sales Value Share by Application (2021-2032) Figure 27. Global NK Cells Sales by Region: 2021 VS 2025 VS 2032 (g) Figure 28. Global NK Cells Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global NK Cells Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global NK Cells Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America NK Cells Sales Value (2021-2032) & (US$ Million) Figure 32. North America NK Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe NK Cells Sales Value (2021-2032) & (US$ Million) Figure 34. Europe NK Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific NK Cells Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific NK Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America NK Cells Sales Value (2021-2032) & (US$ Million) Figure 38. South America NK Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa NK Cells Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa NK Cells Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt NK Cells Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt NK Cells Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt NK Cells Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. NK Cells Value Chain Figure 126. Manufacturing Cost Structure Figure 127. NK Cells Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Mogamulizumab
  • Lorvotuzumab Mertansine
  • Others
Applications
  • Cancer
  • Cardiovascular Diseases
  • Others
Companies covered
  • Affimed NV
  • Altor BioScience
  • Chipscreen Biosciences
  • Fortress Biotech
  • Henry Ford Health Services
  • Innate Pharma
  • NantKwest
  • NKT
  • Sorrento Therapeutics
  • Bristol-Myers Squibb
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global NK Cells Sales Value (2021-2032)
  4. 1.2.2 Global NK Cells Sales Volume (2021-2032)
  5. 1.2.3 Global NK Cells Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 NK Cells Market Dynamics
  1. 2.1 NK Cells Industry Trends
  2. 2.2 NK Cells Industry Drivers
  3. 2.3 NK Cells Industry Opportunities and Challenges
  4. 2.4 NK Cells Industry Restraints
3 NK Cells Market by Company
  1. 3.1 Global NK Cells Company Revenue Ranking in 2025
  2. 3.2 Global NK Cells Revenue by Company (2021-2026)
  3. 3.3 Global NK Cells Sales Volume by Company (2021-2026)
  4. 3.4 Global NK Cells Average Price by Company (2021-2026)
  5. 3.5 Global NK Cells Company Ranking (2024-2026)
  6. 3.6 Global NK Cells Company Manufacturing Base and Headquarters
  7. 3.7 Global NK Cells Company Product Type and Application
  8. 3.8 Global NK Cells Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global NK Cells Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 NK Cells Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 NK Cells Market by Type
  1. 4.1 NK Cells Type Introduction
  2. 4.1.1 Mogamulizumab
  3. 4.1.2 Lorvotuzumab Mertansine
  4. 4.1.3 Others
  5. 4.2 Global NK Cells Sales Volume by Type
  6. 4.2.1 Global NK Cells Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global NK Cells Sales Volume by Type (2021-2032)
  8. 4.2.3 Global NK Cells Sales Volume Share by Type (2021-2032)
  9. 4.3 Global NK Cells Sales Value by Type
  10. 4.3.1 Global NK Cells Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global NK Cells Sales Value by Type (2021-2032)
  12. 4.3.3 Global NK Cells Sales Value Share by Type (2021-2032)
5 NK Cells Market by Application
  1. 5.1 NK Cells Application Introduction
  2. 5.1.1 Cancer
  3. 5.1.2 Cardiovascular Diseases
  4. 5.1.3 Others
  5. 5.2 Global NK Cells Sales Volume by Application
  6. 5.2.1 Global NK Cells Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global NK Cells Sales Volume by Application (2021-2032)
  8. 5.2.3 Global NK Cells Sales Volume Share by Application (2021-2032)
  9. 5.3 Global NK Cells Sales Value by Application
  10. 5.3.1 Global NK Cells Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global NK Cells Sales Value by Application (2021-2032)
  12. 5.3.3 Global NK Cells Sales Value Share by Application (2021-2032)
6 NK Cells Regional Sales and Value Analysis
  1. 6.1 Global NK Cells Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global NK Cells Sales by Region (2021-2032)
  3. 6.2.1 Global NK Cells Sales by Region: 2021-2026
  4. 6.2.2 Global NK Cells Sales by Region (2027-2032)
  5. 6.3 Global NK Cells Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global NK Cells Sales Value by Region (2021-2032)
  7. 6.4.1 Global NK Cells Sales Value by Region: 2021-2026
  8. 6.4.2 Global NK Cells Sales Value by Region (2027-2032)
  9. 6.5 Global NK Cells Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America NK Cells Sales Value (2021-2032)
  12. 6.6.2 North America NK Cells Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe NK Cells Sales Value (2021-2032)
  15. 6.7.2 Europe NK Cells Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific NK Cells Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific NK Cells Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America NK Cells Sales Value (2021-2032)
  21. 6.9.2 South America NK Cells Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa NK Cells Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa NK Cells Sales Value Share by Country, 2025 VS 2032
7 NK Cells Country-level Sales and Value Analysis
  1. 7.1 Global NK Cells Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global NK Cells Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global NK Cells Sales by Country (2021-2032)
  4. 7.3.1 Global NK Cells Sales by Country (2021-2026)
  5. 7.3.2 Global NK Cells Sales by Country (2027-2032)
  6. 7.4 Global NK Cells Sales Value by Country (2021-2032)
  7. 7.4.1 Global NK Cells Sales Value by Country (2021-2026)
  8. 7.4.2 Global NK Cells Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA NK Cells Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA NK Cells Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA NK Cells Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada NK Cells Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada NK Cells Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada NK Cells Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico NK Cells Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico NK Cells Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico NK Cells Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany NK Cells Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany NK Cells Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany NK Cells Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France NK Cells Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France NK Cells Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France NK Cells Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. NK Cells Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. NK Cells Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. NK Cells Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy NK Cells Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy NK Cells Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy NK Cells Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain NK Cells Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain NK Cells Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain NK Cells Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia NK Cells Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia NK Cells Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia NK Cells Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands NK Cells Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands NK Cells Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands NK Cells Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries NK Cells Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries NK Cells Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries NK Cells Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China NK Cells Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China NK Cells Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China NK Cells Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan NK Cells Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan NK Cells Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan NK Cells Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea NK Cells Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea NK Cells Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea NK Cells Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India NK Cells Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India NK Cells Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India NK Cells Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia NK Cells Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia NK Cells Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia NK Cells Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia NK Cells Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia NK Cells Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia NK Cells Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil NK Cells Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil NK Cells Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil NK Cells Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina NK Cells Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina NK Cells Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina NK Cells Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile NK Cells Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile NK Cells Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile NK Cells Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia NK Cells Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia NK Cells Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia NK Cells Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru NK Cells Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru NK Cells Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru NK Cells Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia NK Cells Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia NK Cells Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia NK Cells Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel NK Cells Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel NK Cells Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel NK Cells Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE NK Cells Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE NK Cells Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE NK Cells Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey NK Cells Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey NK Cells Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey NK Cells Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran NK Cells Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran NK Cells Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran NK Cells Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt NK Cells Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt NK Cells Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt NK Cells Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Affimed NV
  2. 8.1.1 Affimed NV Company Information
  3. 8.1.2 Affimed NV Business Overview
  4. 8.1.3 Affimed NV NK Cells Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Affimed NV NK Cells Product Portfolio
  6. 8.1.5 Affimed NV Recent Developments
  7. 8.2 Altor BioScience
  8. 8.2.1 Altor BioScience Company Information
  9. 8.2.2 Altor BioScience Business Overview
  10. 8.2.3 Altor BioScience NK Cells Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Altor BioScience NK Cells Product Portfolio
  12. 8.2.5 Altor BioScience Recent Developments
  13. 8.3 Chipscreen Biosciences
  14. 8.3.1 Chipscreen Biosciences Company Information
  15. 8.3.2 Chipscreen Biosciences Business Overview
  16. 8.3.3 Chipscreen Biosciences NK Cells Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences NK Cells Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Recent Developments
  19. 8.4 Fortress Biotech
  20. 8.4.1 Fortress Biotech Company Information
  21. 8.4.2 Fortress Biotech Business Overview
  22. 8.4.3 Fortress Biotech NK Cells Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Fortress Biotech NK Cells Product Portfolio
  24. 8.4.5 Fortress Biotech Recent Developments
  25. 8.5 Henry Ford Health Services
  26. 8.5.1 Henry Ford Health Services Company Information
  27. 8.5.2 Henry Ford Health Services Business Overview
  28. 8.5.3 Henry Ford Health Services NK Cells Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Henry Ford Health Services NK Cells Product Portfolio
  30. 8.5.5 Henry Ford Health Services Recent Developments
  31. 8.6 Innate Pharma
  32. 8.6.1 Innate Pharma Company Information
  33. 8.6.2 Innate Pharma Business Overview
  34. 8.6.3 Innate Pharma NK Cells Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Innate Pharma NK Cells Product Portfolio
  36. 8.6.5 Innate Pharma Recent Developments
  37. 8.7 NantKwest
  38. 8.7.1 NantKwest Company Information
  39. 8.7.2 NantKwest Business Overview
  40. 8.7.3 NantKwest NK Cells Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 NantKwest NK Cells Product Portfolio
  42. 8.7.5 NantKwest Recent Developments
  43. 8.8 NKT
  44. 8.8.1 NKT Company Information
  45. 8.8.2 NKT Business Overview
  46. 8.8.3 NKT NK Cells Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 NKT NK Cells Product Portfolio
  48. 8.8.5 NKT Recent Developments
  49. 8.9 Sorrento Therapeutics
  50. 8.9.1 Sorrento Therapeutics Company Information
  51. 8.9.2 Sorrento Therapeutics Business Overview
  52. 8.9.3 Sorrento Therapeutics NK Cells Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Sorrento Therapeutics NK Cells Product Portfolio
  54. 8.9.5 Sorrento Therapeutics Recent Developments
  55. 8.10 Bristol-Myers Squibb
  56. 8.10.1 Bristol-Myers Squibb Company Information
  57. 8.10.2 Bristol-Myers Squibb Business Overview
  58. 8.10.3 Bristol-Myers Squibb NK Cells Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Bristol-Myers Squibb NK Cells Product Portfolio
  60. 8.10.5 Bristol-Myers Squibb Recent Developments
  61. 8.11 Takeda
  62. 8.11.1 Takeda Company Information
  63. 8.11.2 Takeda Business Overview
  64. 8.11.3 Takeda NK Cells Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Takeda NK Cells Product Portfolio
  66. 8.11.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 NK Cells Value Chain Analysis
  2. 9.1.1 NK Cells Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 NK Cells Sales Mode & Process
  6. 9.2 NK Cells Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 NK Cells Distributors
  9. 9.2.3 NK Cells Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst